The clinical course of bone metastases from breast cancer.
All patients with carcinoma of the breast seen in this Unit since 1970 were reviewed to study the incidence, prognosis, morbidity and response to treatment of bone metastases. The biological characteristics of the primary tumour were compared in patients relapsing first in bone or liver. Sixty-nine...
Main Authors: | Coleman, R. E., Rubens, R. D. |
---|---|
Format: | Online |
Language: | English |
Published: |
1987
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001575/ |
Similar Items
-
Clinical course and prognostic factors following bone recurrence from breast cancer.
by: Coleman, R. E., et al.
Published: (1998) -
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
by: Coleman, R. E., et al.
Published: (1988) -
Biochemical prediction of response of bone metastases to treatment.
by: Coleman, R. E., et al.
Published: (1988) -
Role of TGF-β in breast cancer bone metastases
by: Chiechi, Antonella, et al.
Published: (2013) -
Therapeutic targets for bone metastases in breast cancer
by: Clézardin, Philippe
Published: (2011)